State Street Corp Coh Bar, Inc. Transaction History

State Street Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	BUY	$0.96 - $1.62 $96,138 - $162,233	100,144 New	100,144 $96,000
Q2 2021 Aug 16, 2021	SELL	$1.09 - $1.49 $448,186 - $612,658	-411,180 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$1.26 - $2.02 $58,338 - $93,526	46,300 Added 12.69%	411,180 $559,000
Q4 2020 Feb 16, 2021	BUY	$0.9 - $1.54 $146,880 - $251,329	163,201 Added 80.92%	364,880 $489,000
Q3 2020 Nov 10, 2020	SELL	$0.87 - $2.08 $1,443 - $3,450	-1,659 Reduced 0.82%	201,679 $192,000
Q2 2020 Aug 14, 2020	BUY	$1.08 - $4.0 $219,605 - $813,352	203,338 New	203,338 $315,000

1.14K

Ticker CWBR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,906,940
Market Cap $1.57M
Description
CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis, type 2 diabetes, acute...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.